Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 0.840-0.840 for the period. The company issued revenue guidance of $12.0 billion-$12.0 billion.
Daiichi Sankyo Stock Performance
Shares of OTCMKTS DSNKY opened at $27.94 on Friday. Daiichi Sankyo has a 52-week low of $25.11 and a 52-week high of $42.48. The firm has a 50 day moving average price of $28.49 and a 200 day moving average price of $32.99.
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter.
About Daiichi Sankyo
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Read More
- Five stocks we like better than Daiichi Sankyo
- Stock Market Sectors: What Are They and How Many Are There?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What does consumer price index measure?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Most Volatile Stocks, What Investors Need to Know
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
